Medipal HoldingsTSE:7459 -2.82%81 PB Ratio is 0.83 as of Jul. 11, 2026, which is 6% below its 10-year median of 0.88. GuruFocus rates TSE:7459 with a GF Score™ of 81/100 and a GF Value™ of 円2,732.17 (Fairly Valued). The stock has 1 warning sign investors should review. Among 110 Medical Distribution companies, Medipal Holdings ranks better than 64.55% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-11), Medipal Holdings's share price is 円2636.00. Medipal Holdings's Book Value per Share for the quarter that ended in Mar. 2026 was 円3,186.00. Hence, Medipal Holdings's PB Ratio of today is 0.83.
The historical rank and industry rank for Medipal Holdings's PB Ratio or its related term are showing as below:
TSE:7459'
s PB Ratio Range Over the Past 10 Years
Min: 0.63 Med: 0.88 Max: 1.2
Current: 0.84
During the past 13 years, Medipal Holdings's highest PB Ratio was 1.20. The lowest was 0.63. And the median was 0.88.
TSE:7459's PB Ratio is ranked better than 64.55% of 110
companies
in the Medical Distribution industry
Industry Median: 1
vs TSE:7459: 0.84
During the past 12 months, Medipal Holdings's average Book Value Per Share Growth Rate was 6.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 5.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.30% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Medipal Holdings was 14.10% per year. The lowest was 1.00% per year. And the median was 5.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Medipal Holdings PB Ratio Related Terms
Medipal Holdings PB Ratio Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Medipal Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings PB Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Medipal Holdings (TSE:7459) has a PB Ratio of 0.83 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medipal Holdings and its competitors. This is near median its historical median of 0.88. Over the past decade, Medipal Holdings' PB Ratio has ranged from 0.63 to 1.20. According to the industry distribution chart, Medipal Holdings ranks #39 out of 110 companies in the Medical Distribution industry, placing it in the top 35.5%.
Is Medipal Holdings' PB Ratio too high?
Medipal Holdings' current PB Ratio of 0.83 is near median its 10-year median of 0.88. Over the past 10 years, this metric has ranged from a low of 0.63 to a high of 1.20. The Medical Distribution industry median PB Ratio is 1.00. Medipal Holdings' value of 0.83 is 17% below this industry median. Based on the distribution chart, Medipal Holdings ranks #39 out of 110 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medipal Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' PB Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #39 out of 110 companies for PB Ratio. This puts Medipal Holdings in the upper half of its industry. The industry median PB Ratio is 1.00. Medipal Holdings' value of 0.83 is 17% below this benchmark. Historically, Medipal Holdings' own PB Ratio has ranged from 0.63 to 1.20 over the past decade. While the company's 10-year median is 0.88 vs. the industry median of 1.00, Medipal Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.00, based on 110 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current PB Ratio of 0.83 is 17% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Medipal Holdings and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current PB Ratio is 0.83, which is near median its own 10-year median of 0.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (TSE:7459) is currently considered Fairly Valued. The stock's GF Value™ is 円2,732.17, compared to a current price of 円2,636.00 — trading 3.5% below its estimated fair value. The current PB Ratio is 0.83, which is near median its 10-year median of 0.88 and 17% below the Medical Distribution industry median of 1.00. Medipal Holdings' overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Medipal Holdings (TSE:7459), the current PB Ratio is 0.83 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (TSE:7459) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be undervalued.
The current stock price of 円2,636.00 is trading 3.5% below its estimated GF Value™ of 円2,732.17.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for TSE:7459:
PB Ratio: 0.83 (near median its 10-year median of 0.88)
GF Value™: 円2,732.17 vs. price of 円2,636.00 (3.5% below fair value)
Industry Position: 17% below the Medical Distribution median (#39 of 110)
No single metric tells the full story. See the TSE:7459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
81GF Score
Get the complete analysis for TSE:7459
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7459 has been successfully added to your 
